Prof. Tore Bengtsson, Co-Founder & Chief Scientific Officer 

Prof. Tore Bengtsson is the Co-Founder and Chief Scientific Officer of Sigrid Therapeutics AB. He is specialised in physiology and molecular biosciences at Stockholm University, leading an international group of scientists in metabolism, obesity and its related diseases at the Department of Molecular Biosciences, the Wenner-Gren Institute, at Stockholm University.

Prof. Bengtsson has a broad experience from commercialising scientific research discoveries. He has been involved in a number of projects in collaboration with with Big Pharma companies and several successful startups, including Atrogi AB, Glucox Biotechnology AB and Symcel AB.

Education
Ph.D., Physiology, Stockholm University